These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 12540788

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
    Bolognesi M, Sacerdoti D, Merkel C, Caregaro L, Bellon S, Gatta A.
    Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
    Jones AL, Bangash IH, Walker J, Simpson KJ, Finlayson ND, Hayes PC.
    Gut; 1995 Jan; 36(1):104-9. PubMed ID: 7890211
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
    Schepis F, Vukotic R, Berzigotti A, Carrión JA, Forns X, Abraldes JG, García-Valdecasas JC, Navasa M, García-Pagán JC, Bosch J.
    Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound].
    Sánchez del Monte J, Ramos Gómez MV, Velazquez Ochoa E.
    Rev Gastroenterol Mex; 2005 Apr; 70(3):261-8. PubMed ID: 17063781
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.
    Luca A, García-Pagán JC, Feu F, Lopez-Talavera JC, Fernández M, Bru C, Bosch J, Rodés J.
    Hepatology; 1995 Jan; 21(1):83-8. PubMed ID: 7806173
    [Abstract] [Full Text] [Related]

  • 36. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
    Escorsell A, Bordas JM, Feu F, García-Pagán JC, Ginès A, Bosch J, Rodés J.
    Gastroenterology; 1997 Nov; 113(5):1640-6. PubMed ID: 9352867
    [Abstract] [Full Text] [Related]

  • 37. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD, Plevris JN, Redhead DN, Bouchier IA, Hayes PC.
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [Abstract] [Full Text] [Related]

  • 38. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M, Chesta J, Bosch J, Rodés J.
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
    Merkel C, Sacerdoti D, Bolognesi M, Buonamico P, Sticca A, Amodio P, Angeli P, Micotti L, Gatta A.
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1221-5. PubMed ID: 10563530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.